Literature DB >> 27912110

Structures and mechanisms of CRISPR RNA-guided effector nucleases.

Hiroshi Nishimasu1, Osamu Nureki2.   

Abstract

In the prokaryotic CRISPR-Cas adaptive immune systems, a CRISPR RNA (crRNA) assembles with multiple or single Cas proteins to form crRNA ribonucleoprotein (crRNP) effector complexes, responsible for the destruction of invading genetic elements. Although the mechanisms of target recognition and cleavage by the crRNP effectors are quite diverse among the different types of CRISPR-Cas systems, the basic action principles of these crRNA-guided effector nucleases are highly conserved. In all of the crRNP effectors, the repeat-derived invariant and spacer-derived variable segments of the crRNA are recognized by the Cas protein(s) in sequence-dependent and sequence-independent manners, respectively, with the spacer-derived guide segment available for base pairing with target nucleic acids. Over the past few years, intensive studies have provided an atomic view of the crRNA-guided target interference mechanisms in different types of CRISPR-Cas systems. Here, we review the recent progress toward structural and mechanistic understanding of the diverse crRNP effector nucleases.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 27912110     DOI: 10.1016/j.sbi.2016.11.013

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  29 in total

Review 1.  Understanding the mechanistic basis of non-coding RNA through molecular dynamics simulations.

Authors:  Giulia Palermo; Lorenzo Casalino; Alessandra Magistrato; J Andrew McCammon
Journal:  J Struct Biol       Date:  2019-03-15       Impact factor: 2.867

2.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

3.  Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System.

Authors:  Yibei Xiao; Min Luo; Robert P Hayes; Jonathan Kim; Sherwin Ng; Fang Ding; Maofu Liao; Ailong Ke
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

4.  Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis.

Authors:  Sergey A Shmakov; Kira S Makarova; Yuri I Wolf; Konstantin V Severinov; Eugene V Koonin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

5.  Inconclusive studies on possible CRISPR-Cas off-targets should moderate expectations about enzymes that have evolved to be non-specific.

Authors:  Sandeep Chakraborty
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

Review 6.  Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.

Authors:  Stefano Stella; Pablo Alcón; Guillermo Montoya
Journal:  Nat Struct Mol Biol       Date:  2017-10-16       Impact factor: 15.369

7.  Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.

Authors:  Takashi Yamano; Bernd Zetsche; Ryuichiro Ishitani; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Mol Cell       Date:  2017-08-03       Impact factor: 17.970

8.  Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1.

Authors:  Hiroshi Nishimasu; Takashi Yamano; Linyi Gao; Feng Zhang; Ryuichiro Ishitani; Osamu Nureki
Journal:  Mol Cell       Date:  2017-06-06       Impact factor: 17.970

9.  Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.

Authors:  Hui Yang; Dinshaw J Patel
Journal:  Mol Cell       Date:  2017-06-09       Impact factor: 17.970

10.  Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex.

Authors:  Tai Wei Guo; Alberto Bartesaghi; Hui Yang; Veronica Falconieri; Prashant Rao; Alan Merk; Edward T Eng; Ashleigh M Raczkowski; Tara Fox; Lesley A Earl; Dinshaw J Patel; Sriram Subramaniam
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.